| The upcoming field of theranostic nanomedicine: an overview. | |
| | |
MedLine Citation:
|
PMID: 23029995 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
Nanocarriers have drastically changed the face of health care by making a mark in diverse arenas of diagnosis, drug delivery, and gene delivery to name a few. The recent feat in nanotechnology has been the birth of nanotheranostics which aims at blending both therapeutic and diagnostic functions within a single nanoscaffold. The field of theranostic nanomedicine is a result of fruitful advances in fields of material science, imaging modalities, formulation development, and molecular biology. Theranostic nanomedicine that was at first developed for enhancing the quality of treatment meted out to cancer patients has now been explored even in atherosclerosis and infections, albeit to a lower extent. The review summarizes various types of nanocarriers that have been explored with one or sometimes multiple imaging modalities for an array of applications ranging from drug delivery and gene delivery to photosensitizing agent delivery for photodynamic therapy. The article also highlights the few but significant developments made in the field of theranostic nanomedicine for atherosclerosis and infections. In conclusion, theranostic nanomedicine is a rapidly growing field. However, there are a few problems that need to be addressed before theranostic nanocarriers carve a niche for themselves in the clinic. |
| | |
Authors:
|
Priyanka Prabhu; Vandana Patravale |
Related Documents
:
|
23639215 - Detection experiments with humans implicate visual predation as a driver of colour poly... 22912625 - Unmasking the perky effect: spatial extent of image interference on visual acuity. 22830725 - Effects of image charges, interfacial charge discreteness, and surface roughness on the... 17724365 - Effect of a robotic prescription-filling system on pharmacy staff activities and prescr... 20617435 - Molecular imaging of angiogenesis with spect. 21076685 - Fast numerical solutions of patient-specific blood flows in 3d arterial systems. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Journal of biomedical nanotechnology Volume: 8 ISSN: 1550-7033 ISO Abbreviation: J Biomed Nanotechnol Publication Date: 2012 Dec |
Date Detail:
|
Created Date: 2012-10-03 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101230869 Medline TA: J Biomed Nanotechnol Country: United States |
Other Details:
|
Languages: eng Pagination: 859-82 Citation Subset: IM |
Affiliation:
|
Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Matunga, Mumbai 400019, India. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: [Management of arterial hypertension in Tunisia: the challenge of a developing country].
Next Document: Local field enhanced Au/CuS nanocomposites as efficient photothermal transducer agents for cancer tr...